Welcome to the e-CCO Library!

P469 Stay in class or switch out of class after anti-TNF failure in inflammatory bowel disease (IBD). Real-world data from a large district general hospital
Year: 2020
Source:

ECCO'20 Vienna

Authors:

H. Johnson, S. Vythilingam, S. McLaughlin

Created: Thursday, 30 January 2020, 10:12 AM
P469: Changes in peripheral blood lymphocyte subsets induced by azathioprine in Crohn’s disease patients
Year: 2016
Source: ECCO '16 Amsterdam
Authors:

A. Labidi*, M. Fekih, N. Ben Mustapha, S. Ben Amor, M. Serghini, L. Kallel, J. Boubaker, A. Filali

Created: Friday, 22 February 2019, 9:49 AM
P469: Effect of mirikizumab on clinical and endoscopic outcomes based on prior advanced therapy failure in patients with moderately to severely active ulcerative colitis
Year: 2023
Source: ECCO’23 Copenhagen
Authors: Navabi, S.(1)*;D'Haens, G.(2);Samaan, K.H.(3);Li, X.(3);Arora, V.(3);Redondo, I.(3);Danese, S.(4);
Created: Friday, 14 July 2023, 11:05 AM
P469: Effectiveness of dose optimisation by pre-genotyping NUDT 15 R139C on reducing thiopurine-induced leucopoenia in Chinese patients with Crohn’s disease: a randomised controlled trial
Year: 2019
Source:

ECCO '19 Copenhagen

Authors:

K. Chao*1, L. Lin1, Y. Huang2, C. Zhang3, J. Huang1, Q. Cao2, X. Gao1, K. Chao1

Created: Friday, 22 February 2019, 9:41 AM
P469: Infliximab for induction of medically-induced remission in Crohn's disease: a Cochrane systematic review
Year: 2022
Source: ECCO'22
Authors: Radford, S.(1);Sinopoulou, V.(2);Gordon, M.(2);Eldragini, M.E.A.A.(1);Darie, A.M.(1);Akobeng, A.(3);Moran, G.W.(1);
Created: Friday, 11 February 2022, 3:52 PM
P469: Safety, tolerability, and pharmacokinetics of the intestine-restricted oral pan-Janus kinase inhibitor TD-1473 after single and multiple oral doses in healthy subjects
Year: 2017
Source: ECCO '17 Barcelona
Authors:

Ferslew B.*1, Sherman C.2, Nguyen D.3, Graham R.1

Created: Wednesday, 20 February 2019, 10:36 AM
P469: Self-reported cutaneous side effects of anti-TNF therapy in inflammatory bowel disease patients
Year: 2018
Source: ECCO '18 Vienna
Authors:

A. Ridge1*, C. Gallagher2, C. Judge1, J. Campion1, D. Mc Namara2,3,4, D. Kevans1,3,4

Created: Thursday, 21 February 2019, 9:14 AM
P469: The PROPER study: interim analysis of a pan-European real-world study of SB5 adalimumab biosimilar after transition from reference adalimumab in patients with Crohn’s disease
Year: 2021
Source: ECCO'21 Virtual
Authors: Dignass, A.(1);Gisbert, J.(2);Freudensprung, U.(3);Addison, J.(4);
Created: Wednesday, 2 June 2021, 4:12 PM
P470 The concept of illness identity in inflammatory bowel disease
Year: 2020
Source:

ECCO'20 Vienna

Authors:

L.L. Knödler1, A. Thomann2, M.P. Ebert2, S. Lis3, W. Reindl2

Created: Thursday, 30 January 2020, 10:12 AM
P470: Comparative effectiveness analysis of flares, hospitalisations, and corticosteroid use among biologic naïve patients with inflammatory bowel disease within 12 months of initiation of vedolizumab or infliximab
Year: 2017
Source: ECCO '17 Barcelona
Authors:

Alam N.1, Raluy-Callado M.1, Gardstein B.2, Curtis R.3, Khalid J.M.*3

Created: Wednesday, 20 February 2019, 10:36 AM
P470: DUBLIN (Degree of Ulcerative colitis Burden of Luminal INflammation) score, a simple method to quantify inflammatory burden in ulcerative colitis
Year: 2019
Source:

ECCO '19 Copenhagen

Authors:

C. R. Rowan*1, G. Cullen1, H. E. Mulcahy1, J. Sheridan1, A. C. Moss2,3, E. J. Ryan1, G. A. Doherty1

Created: Friday, 22 February 2019, 9:41 AM
P470: Early change in faecal calprotectin during anti-TNFα initiation is strongly predictive of outcome in Crohn’s disease
Year: 2016
Source: ECCO '16 Amsterdam
Authors:

P. Pavlidis*, G. Chung- Faye, P. Dubois, I. Bjarnason, B. H. Hayee

Created: Friday, 22 February 2019, 9:49 AM
P470: Evolution of asymptomatic unresected lesions in patients operated for multifocal Crohn's disease.
Year: 2023
Source: ECCO’23 Copenhagen
Authors: Abdalla, S.(1)*;Lelievre, O.(2);Carbonnel, F.(3);Penna, C.(4);Benoist, S.(5);Brouquet, A.(5);
Created: Friday, 14 July 2023, 11:05 AM
P470: Improving IBD-related pregnancy knowledge with a specialised preconception and pregnancy in IBD clinic
Year: 2018
Source: ECCO '18 Vienna
Authors:

N. Rodriguez, L. Ambrosio, L. Dieleman, B. Halloran, K.I. Kroeker, F. Peerani, K. Wong, R.N. Fedorak, V.W. Huang*

Created: Thursday, 21 February 2019, 9:14 AM
P470: Real-world characteristics and complications of patients with Ulcerative Colitis receiving conventional therapy in the public healthcare system in Brazil
Year: 2022
Source: ECCO'22
Authors: Galhardi Gasparini, R.(1);Yukie Sassaki, L.(2);Lima Martins, A.(3);Saad Hossne, R.(4);Watanabe de Oliveira, R.(5);Yang Santos, C.(6);Biatti Barreto, T.(7);
Created: Friday, 11 February 2022, 3:52 PM
P470: Ustekinumab Trough Levels are not Associated with Clinical Response in Inflammatory Bowel Disease Patients
Year: 2021
Source: ECCO'21 Virtual
Authors: Zelinkova, Z.(1);Lipovska, A.(2);Otottova, K.(2);Lucenicova, J.(3);Kadleckova, B.(2);
Created: Wednesday, 2 June 2021, 4:12 PM
P471 What is the appropriate cut-off value of CRP to predict endoscopic remission in ulcerative colitis patients with clinical remission?
Year: 2020
Source:

ECCO'20 Vienna

Authors:

J. Shin, G. Seong, J.H. Song, S.M. Kong, T.J. Kim, E.R. Kim, S.N. Hong, D.K. Chang, Y.H. Kim

Created: Thursday, 30 January 2020, 10:12 AM
P471: A Transcriptome-dependent Prognostic Model of Response in Patients with Ulcerative Colitis
Year: 2023
Source: ECCO’23 Copenhagen
Authors: Johnson, T.(1);Reinisch, W.(2);Steere, B.(3);Milch, C.(4);Harris, C.(3);Morris, N.(3);D'Haens, G.(5);Huang, K.(1);Krishnan, V.(3)*;
Created: Friday, 14 July 2023, 11:05 AM
P471: Association of vedolizumab levels with clinical and biochemical markers of inflammation during maintenance therapy in inflammatory bowel disease
Year: 2019
Source:

ECCO '19 Copenhagen

Authors:

N. Plevris*1, G. R. Jones1, P. W. Jenkinson1, C. S. Chuah1, M. Lyons1, L. M. Merchant1, R. J. Pattenden1, I. D. Arnott1, C. W. Lees1

Created: Friday, 22 February 2019, 9:41 AM
P471: Clinical characteristics and complications in hospitalised elderly patients with ulcerative colitis in a real-world specialised hospital
Year: 2018
Source: ECCO '18 Vienna
Authors:

Y. Kita1*, A. Fujimori1, R. Koshiba1, K. Fujimoto1, T. Sato1, M. Kawai2, K. Kamikozuru1, T. Takagawa2, Y. Yukoyama1, T. Miyazaki1, K. Watanabe2, N. Hida1, S. Nakamura1

Created: Thursday, 21 February 2019, 9:14 AM